Stem Cell Therapy and Nanodelivery Systems for Tissue Engineering
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 3305
Special Issue Editor
Special Issue Information
Dear Colleagues,
Stem cells possess remarkable potential for tissue regeneration due to their differentiation and proliferative capabilities. Utilizing biomaterials that can modulate the biophysical and biochemical cues of stem cells represents a powerful strategy to enhance their regenerative efficacy. Biomaterials refer to materials that are biocompatible and suitable for in vivo applications. By studying and elucidating the interaction mechanisms between these biomaterials and stem cells, we can improve the regenerative efficacy and ultimately contribute to the treatment of human diseases, thereby extending the human lifespan and improving quality of life.
This Special Issue will cover the use of various biomaterials—such as nanoparticles, hydrogels, and naturally derived or synthetic polymers—in the application of multipotent stem cells for tissue regeneration. It aims to provide researchers in the field with knowledge ranging from basic to applied research. We invite articles on all aspects of the use of biomaterials and multipotent stem cells for tissue regeneration.
Dr. Yoshie Arai
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomaterials
- multipotent stem cells
- tissue regeneration
- adult stem cells
- induced pluripotent stem cells
- cell engineering
- tissue engineering
- organoid
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
